Related Experiment Video
Updated: Sep 4, 2025

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
Overview of COVID-19-Associated Invasive Fungal Infection
Akira A Shishido1, Minu Mathew1, John W Baddley1
1Department of Medicine, Division of Infectious Diseases, University of Maryland School of Medicine, 725 West Lombard Street, Baltimore, MD 21201 USA.
Invasive fungal infections, including aspergillosis and mucormycosis, are serious complications in COVID-19 patients. Early diagnosis and high suspicion are crucial for managing these potentially fatal co-infections.
Area of Science:
- Infectious Diseases
- Mycology
- Critical Care Medicine
Background:
- Invasive fungal infections (IFIs) are increasingly recognized complications in patients with coronavirus disease 2019 (COVID-19).
- These infections can significantly worsen patient outcomes and increase mortality.
- Understanding the spectrum and risk factors of IFIs in COVID-19 is critical for timely management.
Purpose of the Study:
- To review the existing literature on invasive fungal infections associated with COVID-19.
- To characterize the types of fungal pathogens involved and their clinical presentations.
- To identify risk factors and diagnostic challenges in COVID-19-associated fungal diseases.
Main Methods:
- Systematic review of published literature.
- Analysis of reported cases of invasive fungal infections in COVID-19 patients.
- Synthesis of data on fungal species, risk factors, and diagnostic approaches.
Main Results:
- Common IFIs include COVID-19-associated pulmonary aspergillosis (CAPA) and COVID-19-associated mucormycosis (CAM).
- Other reported fungal infections include candidiasis, pneumocystosis, and non-Aspergillus molds.
- Key risk factors identified are underlying lung disease, diabetes, corticosteroid use, and immunosuppression.
Conclusions:
- Fungal pathogens pose a significant threat to patients with COVID-19, often increasing mortality.
- Diagnostic strategies for IFIs in COVID-19 are evolving and require a high index of clinical suspicion.
- Further research is needed to understand pathogenesis, optimize management, and develop prevention strategies for these co-infections.
Related Concept Videos
Overview of Fungi
Fungal Phylum Microsporidia
Fungal Group Zygomycota
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Endocarditis I: Introduction

